Corticotropin-releasing factor antagonist attenuates the 'anxiogenic- like' effect in the defensive burying paradigm but not in the elevated plus- maze following chronic cocaine in rats

Psychopharmacology

Volumn 145, Issue 1, 1999, Pages 21-30

  Basso, Ana M ^a,c   Spina, Mariarosa ^a   Koob, George F ^a   Rivier, Jean ^b   Vale, Wylie ^b  

^a Dept of Neuropharmacology CVN 7 ^*  (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Anxiety; Chronic treatment; Cocaine; Corticotropin releasing factor antagonist; Corticotropin releasing factor; D Phe CRF((12 41)); Defensive burying paradigm; Elevated plus maze; Withdrawal

Indexed keywords

CORTICOTROPIN RELEASING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; MAZE TEST; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; STRESS; WITHDRAWAL REFLEX;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; COCAINE; CORTICOTROPIN-RELEASING HORMONE; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032801869     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051028     Document Type: Article

References (75)

1. Aronson TA, Craig TJ (1986) Cocaine precipitation of panic disorder. Am J Psychiatry 143:643-645
2. Baldwin HA, Britton KT, Koob GF (1990) Behavioral effects of corticotropin-releasing factor. In: Pfaff DW, Ganten D (eds) Behavioral Aspects of Neuroendocrinology (Current Topics in Neuroendocrinology, vol 10). Springer, Berlin, pp 1-14
3. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT (1991) CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 103:227-232
4. Britton DR, Koob GF, Rivier J, Vale W (1982) Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31:363-367
5. Britton DR, Varela M, Garcia A, Rosenthal M (1986a) Dexamethasone supresses pituitary-adrenal but not behavioral effects of centrally administered CRF. Life Sci 38:211-216
6. Britton KT, Lee G, Dana R, Risch SC, Koob GF (1986b) Activating and "anxiogenic" effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci 39:1281-1286
7. Britton KT, Lee G, Vale W, Rivier J, Koob GF (1986c) Corticotropin-releasing factor (CRF) receptor antagonist blocks activating and "anxiogenic" actions of CRF in the rat. Brain Res 369:303-306
8. Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W (1982) Corticotropin-releasing factor: Actions on sympathetic nervous system and metabolism. Endocrinology 111:928-931
9. Calogero AE, Gallucci WT, Kling MA, Chrousos GP, Gold PW (1989) Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 505:7-11
10. Chopin P, Briley M (1987) Animal models of anxiety: The effects of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci 8:383-388
11. Costall B, Kelly ME, Onaivi ES, Naylor RJ (1990) The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse. Naunyn-Schmiedeberg's Arch Pharmacol 341:547-551
12. Davis M (1992) The role of the amygdala in fear-potentiated startle: Implications for animal models of anxiety. Trends Pharmacol Sci 13:35-41
13. Dawson GR, Tricklebank MD (1995) Use of the elevated plus-maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33-36
14. De Souza EB (1987) Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution. J Neurosci 7:88-100
15. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ (1985) Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: An autora-diographic study. J Neurosci 5:3189-3203
16. Diamant M, Croiset G, de Wied D (1992) The effect of cortiotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats. Peptides 13:1149-1158
17. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100
18. Dunn AJ, File SE (1987) Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav 21:193-202
19. Eaves M, Thatcher-Britton K, Rivier J, Vale W, Koob GF (1985) Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats. Peptides 6:923-926
20. Emmett-Oglesby MW, Mathis DA, Moon RTY, Lal H (1990) Animal models of drug withdrawal symptoms. Psychopharmacology 101:292-309
21. File SE (1985) Models of anxiety. Br J Clin Pract Symp Suppl 38:15-20
22. File SE, Baldwin HA, Hitchcott PK (1989) Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology 98:262-264
23. Fontana DJ, Commissaris RL (1989) Effects of cocaine on conflict behavior in the rat. Life Sci 45:819-827
24. Gawin FH (1991) Cocaine addiction: Psychology and neurophysiology. Science 251:1580-1586
25. Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: Clinical observations. Arch Gen Psychiatry 43:107-113
26. Goeders NE, Bienvenu OJ, De Souza EB (1990) Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res 531:322-328
27. Grahn RE, Kalman BA, Brennan FX, Watkins LR, Maier SF (1995) The elevated plus-maze is not sensitive to the effect of stressor controllability in rats. Pharmacol Biochem Behav 52:565-570
28. Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders - More than 30 years research. Pharmacol Ther 65:391-395
29. Harris GC, Aston-Jones G (1993) β-Adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology 113:131-136
30. Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF (1992) Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 581:190-197
31. Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21-30
32. Kalin NH, Sherman JE, Takahashi LK (1988) Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res 457:130-135
33. Killcross S, Robbins TW, Everitt BJ (1997) Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 388:377-380
34. Koob GF, Bloom FE (1985) Corticotropin-releasing factor and behavior. Fed Proc 44:259-263
35. Koob GF, Heinrichs SC, Menzaghi F, Merlo-Pich E, Britton KT (1994) Corticotropin releasing factor, stress and behavior. Semin Neurosci 6:221-229
36. Korte SM, Korte-Bouws GAH, Bohus B, Koob GF (1994) Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol Behav 56:115-120
37. Korte SM, De Boer SF, De Kloet ER, Bohus B (1995) Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 20:385-394
38. Korte SM, Korte-Bouws GAH, Koob GF, De Kloet ER, Bohus B (1996) Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety. Pharmacol Biochem Behav 54:261-267
39. Markou A, Hauger RL, Koob GF (1992) Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology 109:305-314
40. Menard J, Treit D (1997) The anxiolytic effects of R(+)-8-OH-DPAT differ in the septum and in the hippocampus. Soc Neurosci Abstr 27:929.12
41. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF (1994) Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 269:564-572
42. Merlo-Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447
43. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473
44. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A Stereotaxic Atlas of the Rat Brain, 2nd Edn. Plenum Press, New York
45. Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in the elevated plus-maze: A novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525-529
46. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
47. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW (1993) Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor. Endocrinology 133:3058-3061
48. Pinel JPJ, Treit D (1978) Burying as a defensive response in rats. J Comp Physiol Psychol 92:708-712
49. Resnick R, Schuyten-Resnick E (1977) Clinical aspects of cocaine: Assessment of cocaine abuse behavior in man. In: Mule SJ (ed) Cocaine. CRC Press, Boca Raton
50. Richter RM, Pich EM, Koob GF, Weiss F (1995) Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187:169-172
51. Rivier CL, Plotsky PM (1986) Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Ann Rev Physiol 48:475-494
52. Rivier C, Vale W (1987) Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res 442:403-406
53. Rodgers RJ, Cole JC (1993) Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol Behav 54:729-736
54. Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276:2050-2054
55. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G (1993) Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res 616:315-319
56. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G(1995) Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res 675:89-97
57. Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W (1982) Corticotropin releasing factor produces behavioral activation in rats. Nature 297:331-333
58. Swanson LW, Sawchenko PE, Rivier J, Vale W (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in rat brain: An immunohistochemical study. Neuroendocrinology 36:165-186
59. Takahashi LK, Kalin NH, Vanden Burgt JA, Sherman JE (1989) Corticotropin-releasing factor modulates defensive withdrawal and exploratory behavior in rats. Behav Neurosci 103:648-654
60. Tazi A, Dantzer R, Le Moal M, Rivier J, Vale W, Koob GF (1987) Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats. Regul Pept 18:37-42
61. Treit D (1985a) Animal models for the study of anti-anxiety agents: A review. Neurosci Biobehav Rev 9:203-222
62. Treit D (1985b) The inhibitory effect of diazepam on defensive burying: Anxiolytic vs. analgesic effects. Pharmacol Biochem Behav 22:47-52
63. Treit D, Pinel JPJ, Terlecki LJ (1980) Shock intensity and conditioned defensive burying in rats. Bull Psychonom Soc 16:5-7
64. Treit D, Pinel JPJ, Fibiger HC (1981) Conditioned defensive burying: A new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15:619-626
65. Treit D, Pesold C, Rotzinger S (1993) Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rats anxiety. Behav Neurosci 107:770-785
66. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397
67. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J (1983) Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 39:245-270
68. Valentino RJ, Foote SL (1988) Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci 8:1016-1025
69. Valentino RJ, Wehby RG (1988) Corticotropin-releasing factor: Evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress. Neuroendocrinology 48:674-677
70. Valentino RJ, Foote SL, Aston-Jones G (1983) Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363-367
71. Valentino RJ, Foote SL, Page ME (1993) The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci 697:173-188
72. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS (1990) Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: A controlled, residential study. Arch Gen Psychiatry 47:861-868
73. Wilkie DM, Mac Lennan AJ, Pinel JPJ (1979) Rat defensive behavior: Burying noxious food. J Exp Anal Behav 31:229-306
74. Wood DM, Lal H (1987) Anxiogenic properties of cocaine withdrawal. Life Sci 41:1431-1436
75. Zangrossi H, File SE (1992) Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull 29:381-388